268 related articles for article (PubMed ID: 21245992)
1. Polymorphisms in NF-κB, PXR, LXR, PPARγ and risk of inflammatory bowel disease.
Andersen V; Christensen J; Ernst A; Jacobsen BA; Tjønneland A; Krarup HB; Vogel U
World J Gastroenterol; 2011 Jan; 17(2):197-206. PubMed ID: 21245992
[TBL] [Abstract][Full Text] [Related]
2. Polymorphisms in NFkB, PXR, LXR and risk of colorectal cancer in a prospective study of Danes.
Andersen V; Christensen J; Overvad K; Tjønneland A; Vogel U
BMC Cancer; 2010 Sep; 10():484. PubMed ID: 20836841
[TBL] [Abstract][Full Text] [Related]
3. Pregnane X receptor (PXR/NR1I2) gene haplotypes modulate susceptibility to inflammatory bowel disease.
Glas J; Seiderer J; Fischer D; Tengler B; Pfennig S; Wetzke M; Beigel F; Olszak T; Weidinger M; Göke B; Ochsenkühn T; Folwaczny M; Müller-Myhsok B; Diegelmann J; Czamara D; Brand S
Inflamm Bowel Dis; 2011 Sep; 17(9):1917-24. PubMed ID: 21830270
[TBL] [Abstract][Full Text] [Related]
4. The pregnane X receptor locus is associated with susceptibility to inflammatory bowel disease.
Dring MM; Goulding CA; Trimble VI; Keegan D; Ryan AW; Brophy KM; Smyth CM; Keeling PW; O'Donoghue D; O'Sullivan M; O'Morain C; Mahmud N; Wikström AC; Kelleher D; McManus R
Gastroenterology; 2006 Feb; 130(2):341-8; quiz 592. PubMed ID: 16472590
[TBL] [Abstract][Full Text] [Related]
5. Pregnane X Receptor Polymorphisms and Risk of Inflammatory Bowel Disease: A Meta-Analysis.
Guo X; Yan M
Immunol Invest; 2017 Aug; 46(6):566-576. PubMed ID: 28742404
[TBL] [Abstract][Full Text] [Related]
6. Role of the PXR gene locus in inflammatory bowel diseases.
Martínez A; Márquez A; Mendoza J; Taxonera C; Fernández-Arquero M; Díaz-Rubio M; de la Concha EG; Urcelay E
Inflamm Bowel Dis; 2007 Dec; 13(12):1484-7. PubMed ID: 17828778
[TBL] [Abstract][Full Text] [Related]
7. Polymorphisms in the inflammatory pathway genes TLR2, TLR4, TLR9, LY96, NFKBIA, NFKB1, TNFA, TNFRSF1A, IL6R, IL10, IL23R, PTPN22, and PPARG are associated with susceptibility of inflammatory bowel disease in a Danish cohort.
Bank S; Skytt Andersen P; Burisch J; Pedersen N; Roug S; Galsgaard J; Ydegaard Turino S; Brodersen JB; Rashid S; Kaiser Rasmussen B; Avlund S; Bastholm Olesen T; Jürgen Hoffmann H; Kragh Thomsen M; Ostergaard Thomsen V; Frydenberg M; Andersen Nexø B; Sode J; Vogel U; Andersen V
PLoS One; 2014; 9(6):e98815. PubMed ID: 24971461
[TBL] [Abstract][Full Text] [Related]
8. Common PPARγ variants C161T and Pro12Ala are not associated with inflammatory bowel disease in an Australian cohort.
Hume GE; Fowler EV; Griffiths LR; Doecke JD; Radford-Smith GL
J Gastrointestin Liver Dis; 2012 Dec; 21(4):349-55. PubMed ID: 23256116
[TBL] [Abstract][Full Text] [Related]
9. Distribution of peroxisome proliferator-activated receptor-gamma polymorphisms in Chinese and Dutch patients with inflammatory bowel disease.
Shrestha UK; Karimi O; Crusius JB; Zhou F; Wang Z; Chen Z; van Bodegraven AA; Xiao J; Morré SA; Wang H; Li J; Xia B
Inflamm Bowel Dis; 2010 Feb; 16(2):312-9. PubMed ID: 19714744
[TBL] [Abstract][Full Text] [Related]
10. Association of peroxisome proliferator-activated receptor gamma polymorphisms with inflammatory bowel disease in a Hungarian cohort.
Poliska S; Penyige A; Lakatos PL; ; Papp M; Palatka K; Lakatos L; Molnar T; Nagy L
Inflamm Bowel Dis; 2012 Mar; 18(3):472-9. PubMed ID: 21710534
[TBL] [Abstract][Full Text] [Related]
11. Hepatic fatty acid transporter Cd36 is a common target of LXR, PXR, and PPARgamma in promoting steatosis.
Zhou J; Febbraio M; Wada T; Zhai Y; Kuruba R; He J; Lee JH; Khadem S; Ren S; Li S; Silverstein RL; Xie W
Gastroenterology; 2008 Feb; 134(2):556-67. PubMed ID: 18242221
[TBL] [Abstract][Full Text] [Related]
12. Probiotics modulate intestinal expression of nuclear receptor and provide counter-regulatory signals to inflammation-driven adipose tissue activation.
Mencarelli A; Distrutti E; Renga B; D'Amore C; Cipriani S; Palladino G; Donini A; Ricci P; Fiorucci S
PLoS One; 2011; 6(7):e22978. PubMed ID: 21829567
[TBL] [Abstract][Full Text] [Related]
13. Peroxisome proliferator-activated receptor γ 2 mutation may cause a subset of ulcerative colitis.
Aoyagi Y; Nagata S; Kudo T; Fujii T; Wada M; Chiba Y; Ohtsuka Y; Yamashiro Y; Shimizu T; Ohkusa T
Pediatr Int; 2010 Oct; 52(5):729-34. PubMed ID: 20591056
[TBL] [Abstract][Full Text] [Related]
14. Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-gamma (PPARgamma) gene in inflammatory bowel disease.
Atug O; Tahan V; Eren F; Tiftikci A; Imeryuz N; Hamzaoglu HO; Tozun N
J Gastrointestin Liver Dis; 2008 Dec; 17(4):433-7. PubMed ID: 19104705
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic role of rifaximin in inflammatory bowel disease: clinical implication of human pregnane X receptor activation.
Cheng J; Shah YM; Ma X; Pang X; Tanaka T; Kodama T; Krausz KW; Gonzalez FJ
J Pharmacol Exp Ther; 2010 Oct; 335(1):32-41. PubMed ID: 20627999
[TBL] [Abstract][Full Text] [Related]
16. Relationship between NR1I2 polymorphisms and inflammatory bowel disease risk: A systematic review and meta-analysis.
Sun MY; Lin JN
Clin Res Hepatol Gastroenterol; 2017 Mar; 41(2):230-239. PubMed ID: 27894906
[TBL] [Abstract][Full Text] [Related]
17. Polymorphisms in the Toll-Like Receptor and the IL-23/IL-17 Pathways Were Associated with Susceptibility to Inflammatory Bowel Disease in a Danish Cohort.
Bank S; Andersen PS; Burisch J; Pedersen N; Roug S; Galsgaard J; Ydegaard Turino S; Brodersen JB; Rashid S; Kaiser Rasmussen B; Avlund S; Bastholm Olesen T; Hoffmann HJ; Andersen Nexø B; Sode J; Vogel U; Andersen V
PLoS One; 2015; 10(12):e0145302. PubMed ID: 26698117
[TBL] [Abstract][Full Text] [Related]
18. Association between the Pro12Ala polymorphism of peroxisome proliferator-activated receptor gamma 2 and inflammatory bowel disease: a meta-analysis.
Zhang ZF; Yang N; Zhao G; Zhu L; Wang LX
PLoS One; 2012; 7(1):e30551. PubMed ID: 22276212
[TBL] [Abstract][Full Text] [Related]
19. Cyclooxygenase-2 (COX-2) polymorphisms and risk of inflammatory bowel disease in a Scottish and Danish case-control study.
Andersen V; Nimmo E; Krarup HB; Drummond H; Christensen J; Ho GT; Ostergaard M; Ernst A; Lees C; Jacobsen BA; Satsangi J; Vogel U
Inflamm Bowel Dis; 2011 Apr; 17(4):937-46. PubMed ID: 20803508
[TBL] [Abstract][Full Text] [Related]
20. The polymorphism rs3024505 proximal to IL-10 is associated with risk of ulcerative colitis and Crohns disease in a Danish case-control study.
Andersen V; Ernst A; Christensen J; Østergaard M; Jacobsen BA; Tjønneland A; Krarup HB; Vogel U
BMC Med Genet; 2010 May; 11():82. PubMed ID: 20509889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
